Showing results (141-150 of 330) with videos related to
Sort By:
Pageof 33
BMC Medical Research Methodology|June 9, 2025
Comparison of total event analysis and first event analysis in relation to heterogeneity in cardiovascular trialsShun-Fu Lee, Chinthanie Ramasundarahettige, Hertzel C Gerstein, et al.Clinical Endocrinology|March 5, 2013
Prospective association of 25(OH)D with metabolic syndromeSheena Kayaniyil, Stewart B Harris, Ravi Retnakaran, et al.Diabetes, Obesity & Metabolism|October 7, 2020
Design and baseline characteristics of the AMPLITUDE-O cardiovascular outcomes trial of efpeglenatide, a weekly glucagon-like peptide-1 receptor agonistHertzel C Gerstein, Kelley Branch, Laura Heenan, et al.Clinical Chemistry|October 20, 2018
A Mendelian Randomization-Based Approach to Identify Early and Sensitive Diagnostic Biomarkers of DiseasePedrum Mohammadi-Shemirani, Jennifer Sjaarda, Hertzel C Gerstein, et al.Cardiovascular Diabetology|November 3, 2023
High BMI and the risk for incident type 1 Diabetes Mellitus: a systematic review and meta-analysis of aggregated cohort studiesMaya Nitecki, Hertzel C Gerstein, Yulia Balmakov, et al.Diabetes Care|October 29, 2002
Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudyEva Lonn, Salim Yusuf, Byrcon Hoogwerf, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 27, 2022
Ease of Use of the iGlarLixi SoloStar Pen from the LixiLan ONE CAN Pen Sub-Study: Questionnaire Findings from People Living with Type 2 Diabetes and Their HealthCare ProvidersJean-François Yale, Aude Roborel de Climens, Naresh Aggarwal, et al.Journal of Diabetes|June 3, 2011
Strategies to detect abnormal glucose metabolism in people at high risk of cardiovascular disease from the ORIGIN (Outcome Reduction with Initial Glargine Intervention) trial populationErik A Badings, Lyanne Dyal, Lydia Schoterman, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 12, 2011
Estimation of the impact of diabetes-related complications on health utilities for patients with type 2 diabetes in Ontario, CanadaDaria J O'Reilly, Feng Xie, Eleanor Pullenayegum, et al.JAMA Network Open|April 26, 2021
Association Between Bariatric Surgery and Major Adverse Diabetes Outcomes in Patients With Diabetes and ObesityAristithes G Doumouras, Yung Lee, J Michael Paterson, et al.Pageof 33